Theresa May urges US makers of cystic fibrosis drug to strike ‘crucial’ deal with NHS

17 May 2019 - Theresa May last night urged US makers of a drug that prolongs life for cystic fibrosis sufferers ...

Read more →

NICE recommends Revlimid as multiple myeloma alternative

17 May 2019 - NICE has recommended Revlimid (lenalidomide), a drug that helps to support the immune system to fight ...

Read more →

Mum delivers 65 roses to Downing Street in bid to speed up NHS availability of vital cystic fibrosis drugs

16 May 2019 - Calls for NHS access to potentially life-saving drugs are growing, one year to the day after ...

Read more →

NHS chief hails SMA drug deal – and was that a swipe at Vertex?

15 May 2019 - Children in England with the rare muscle wasting disease spinal muscular atrophy will get access to ...

Read more →

NICE recommends first ever treatment for children with rare muscle wasting condition

15 May 2019 - Children with the rare genetic disorder spinal muscular atrophy can now be treated with nusinersen after NICE ...

Read more →

Cystic fibrosis drug campaign makes no progress in year

10 May 2019 - It is a year on from the delivery of more than 1,000 letters to Downing Street, ...

Read more →

HTA frameworks for RA therapies need improvement, researchers say

13 May 2019 - Cost-effectiveness models for the treatment of rheumatoid arthritis first emerged in the early 2000s when highly effective ...

Read more →

The UK’s new medicines pricing deal – opportunities and risks for pharma

10 May 2019 - January 2019 saw the introduction of the new Voluntary Scheme for Branded Medicines Pricing and Access  ...

Read more →

MPs call for 'life-changing' Kuvan to be made affordable

11 May 2019 - A number of MPs are calling on a drug company to make a "life-changing" treatment affordable ...

Read more →

Lower price for MS drug paves the way for positive recommendation from NICE

9 May 2019 - A new, lower price for a drug to treat a rarer form of multiple sclerosis in adults ...

Read more →

Hope for multiple sclerosis sufferers after green light for drug which can delay wheelchair use by seven years

9 May 2019 - Multiple sclerosis patients have welcomed an NHS decision to fund a “landmark” drug which can delay ...

Read more →

Proposal to widen access to etanercept and award sole supply

3 May 2019 - PHARMAC is proposing to make changes to the funding of etanercept, a biologic medicine used to ...

Read more →

NICE recommends Roche’s Tecentriq for metastatic NSCLC

3 May 2019 - NICE has published final draft guidance recommending Roche’s Tecentriq in combination with other therapies for metastatic ...

Read more →

NHS England finalises procurement to eliminate hepatitis C

1 May 2019 - After lengthy negotiations and a court battle, NHS England has reached agreement with three drug companies ...

Read more →

NICE launches online resource to help development and adoption of new health technologies

29 April 2019 - HealthTech Connect, a new online resource provided by NICE to help identify and support new health technologies ...

Read more →